Insulin sensitisation in the treatment of Type 2 diabetes. - Wikidata - wikimedia - TriplyDB

Insulin sensitisation in the treatment of Type 2 diabetes.

Insulin sensitisation in the treatment of Type 2 diabetes.

http://www.wikidata.org/entity/Q35073317

about

Expression and functional activity of PPARgamma in pancreatic beta cells.An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia.Fatty liver, hypertension, and the metabolic syndrome.

P2860

Q35047497-C23B3E79-ADEF-4FA2-8399-7EAD26710C42 Q42940455-D7A8B413-6F95-4200-A3E7-4B778967B06A Q43004970-7690A3C0-5A2B-405C-B1B4-B259EEFD6B5A

P2860

Insulin sensitisation in the treatment of Type 2 diabetes.

http://www.wikidata.org/entity/Q35073317

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Insulin sensitisation in the treatment of Type 2 diabetes.

@ast

Insulin sensitisation in the treatment of Type 2 diabetes.

@en

type

label

Insulin sensitisation in the treatment of Type 2 diabetes.

@ast

Insulin sensitisation in the treatment of Type 2 diabetes.

@en

prefLabel

Insulin sensitisation in the treatment of Type 2 diabetes.

@ast

Insulin sensitisation in the treatment of Type 2 diabetes.

@en

P1433

Q35073317-6F12D5E8-847C-4734-93CA-77FEF785C76B

P1476

Q35073317-D48E5FF4-A6A2-4F25-8E7A-C82E74995AFE

P2093

Q35073317-448FAE6E-A572-4BF0-8740-FABF3CDBB8B8

Q35073317-55F271CF-A89C-4EC9-A5D7-DB3FCC0E4E69

P2860

Q35073317-003626F8-23D0-4B2B-8FFE-BD79724CF0A6

Q35073317-032C5E5A-7BCF-4395-BB08-93D1BBE594D6

Q35073317-06A9B85D-5ECC-4D9C-87D5-62A52C5AEDF6

Q35073317-0CA972F6-B912-41C9-B87A-E325BDBD769C

Q35073317-1BA276B0-9BAC-4FE5-8B25-FFF2232A6697

Q35073317-1FAF5576-F114-4F14-B9A3-27107D422EF4

Q35073317-20682FCB-C054-4C44-B5E5-85180763FFB8

Q35073317-283E3AEC-CC0B-4F7A-8736-9CECA04A8DA5

Q35073317-2B5B8099-06B4-41FC-9C48-9B2DF0578162

Q35073317-3018A805-0BB6-42B9-A0E3-2423956E9ACC

P304

Q35073317-626AC1BB-032D-48C4-9950-0CCC86EBF2AE

P31

Q35073317-41E1F199-12D9-4A14-AB00-C0107F11A7DD

P356

Q35073317-F96DC4C2-25F2-4B19-AB29-B26758B5FDE4

P407

Q35073317-9553DCA6-D282-47B5-A059-3E00B1070CDB

P433

Q35073317-582CE9D9-E8C5-47C3-936A-D98542EDA899

P478

Q35073317-338BEC15-E8DD-4E68-AC62-9827B99022A0

P577

Q35073317-C19317D8-E3E2-4832-B0ED-001E39CE19DD

P698

Q35073317-E9DBF799-4BB9-4C98-A237-D2B937668453

P921

Q35073317-E2568D1D-78A7-4B4D-923E-1CD767195CB0

P356

13543784.12.3.307

P1433

Expert Opinion on Investigational Drugs

P1476

Insulin sensitisation in the treatment of Type 2 diabetes.

@en

P2093

Smith SA

http://www.w3.org/2001/XMLSchema#string

Tadayyon M

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin: An Update

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

Disruption of IRS-2 causes type 2 diabetes in mice

Molecular characterization of the human beta 3-adrenergic receptor

Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

P304

307-324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.12.3.307

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12605557

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes